Compound search：Set keywords and then click SEARCH.
Please contact us by using the Inquiry Form
. We will ask for more details by e-mail, so just a brief description is sufficient. You can also contact us from the page that appears by clicking on the structural formula.
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 05950 |  | Sulforhodamine bis(CO-PEG14-COOH) | 68,800/0.1mg | >95% | 1.6 |
| 07609 |  | Glutathione tridecasulfide | 170,000/0.1mg | <80% | 0.7 |
| 06798 |  | Cy5(1-PEG3-OMe 5-SO3H 8,8-diMe 1'-PEG13-COOH 8',8'-diMe) | 133,000/0.1mg | >95% | 0.1 |
| 06461 |  | Cy5(PEG3-OMe)(PEG13-COOtBu) | 133,000/0.1mg | >95% | 0 |
| 06410 |  | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >95% | 0.4 |
| 06401 |  | TMSI-PEG13-OTrt | 68,800/0.1mg | >95% | 0 |
| 06396 |  | AADIS7-PEG13-COOH | 133,000/0.1mg | >95% | 0.3 |
| 06390 |  | AADIS7-PEG13-COOtBu | 105,500/0.1mg | >95% | 0.9 |
| 06311 |  | TMSI-PEG13-COOH | 68,800/0.1mg | >95% | 11.1 |
| 06064 |  | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05373 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >90% | 0.1 |
| 05078 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0 |
| 04746 |  | CF660R-PEG13-PEG2-O-HexCl | 133,000/0.1mg | >95% | 0.1 |
| 04731 |  | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04730 |  | Texas-Red-X-CONH-PEG13-COOH mixed isomers | 69100/<0.1mg | >95% | 0.1 |
| 07608 |  | Glutathione dodecasulfide | 170,000/0.1mg | <80% | 0.6 |
| 06479 |  | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 68,800/0.1mg | >90% | 0.4 |
| 06456 |  | TMSI-PEG12-OMe | 68,800/0.1mg | >80% | 9.0 |
| 06394 |  | TMSI-PEG12-OH | 133,000/0.1mg | >95% | 6.1 |
| 06363 |  | SH-PEG12-SH | 75,000/2.5mg | >90% | 0 |
| 06354 |  | Cyclic(-S-PEG12-S-) | 71,500/0.1mg | >95% | 0 |
| 06338 |  | SCSOEt-PEG12-SCSOEt | 65,700/0.4mg | >90% | 0 |
| 07607 |  | Glutathione undecasulfide | 170,000/0.1mg | <80% | 0.7 |
| 06518 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 68,800/0.1mg | >90% | 0 |
| 06362 |  | SH-PEG11-SH | 71,500/0.2mg | >90% | 0 |
| 07606 |  | Glutathione decasulfide | 170,000/0.3mg | <80% | 0.9 |
| 06402 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 06361 |  | SH-PEG10-SH | 68,400/0.4mg | >90% | 0 |
| 06356 |  | Cyclic(-S-PEG10-) | 84,900/0.1mg | >95% | 0 |
| 06355 |  | Cyclic(-S-PEG4-S-PEG6-) | 84,900/0.1mg | >95% | 0 |
| 06069 |  | TMSI-PEG10-OH | 68,800/0.1mg | >95% | 0.1 |
| 07603 |  | Glutathione nonasulfide | 170,000/0.5mg | >80% | 1.5 |
| 06375 |  | Cyclic(-S-PEG9-) | 84,900/0.1mg | >95% | 3.5 |
| 06068 |  | TMSI-PEG10-OTrt | 63,400/0.2mg | >95% | 9.0 |
| 02749 |  | OH-PEG9-SO3H | 64,000/0.7mg | >95% | 16.2 |
| 01749 |  | SCSOEt-PEG9-SCSOEt | 72,300/2.5mg | >95% | 0 |
| 01724 |  | SH-PEG9-SH | 75,000/2.5mg | >90% | 44.3 |
| 07524 |  | Glutathione octasulfide | 170,000/0.8mg | >90% | 1.7 |
| 06360 |  | SH-PEG8-SH | 88,400/2.5mg | >90% | 0 |
| 06349 |  | Cyclic(-S-PEG5-S-PEG3-) | 84,900/0.1mg | >95% | 0 |
| 06295 |  | TMSI-PEG8-OH | 64,000/0.7mg | >95% | 12.8 |
| 05094 |  | PFOS | 66,100/1mg | >99% | 254.1 |
| 00369 |  | N3-PEG8-COOH | 78,900/2.5mg | >95% | 0 |
| 06866 |  | Glutathione heptasulfide | 170,000/1mg | >90% | 3.2 |
| 06398 |  | TMSI-PEG7-OH | 64,000/0.7mg | >95% | 1.3 |
| 06359 |  | SH-PEG7-SH | 80,100/0.7mg | >90% | 0 |
| 06350 |  | Cyclic(-S-PEG7-S-PEG1-) | 84,900/0.1mg | >95% | 0 |
| 08744 |  | PFHxS | 75,000/2.5mg | >95% | 35.7 |
| 06865 |  | Glutathione hexasulfide | 170,000/2mg | >90% | 9.9 |
| 06516 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06417 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06397 |  | TMSI-PEG6-OH | 64,000/0.7mg | >95% | 1.2 |
| 01794 |  | SH-PEG6-SH | 64,000/0.7mg | >90% | 0 |
| 06862 |  | Glutathione pentasulfide | 170,000/5mg | >90% | 22.8 |
| 06796 |  | AADIS5-PEG5-COOH | 64,000/0.7mg | >95% | 0 |
| 06453 |  | SCNHNH2-PEG5-SCNHNH2 | 68,900/25mg | >95% | 335.0 |
| 06426 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06419 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06377 |  | Cyclic(-S-PEG5-) | 84,900/0.1mg | >95% | 0 |
| 06357 |  | SH-PEG5-SH | 64,000/0.7mg | >90% | 0 |
| 06294 |  | TMSI-PEG5-NHTrt | 68,800/0.1mg | >95% | 2.6 |
| 05343 |  | DMT-PEG5-S-PEG4-ODMT | 68,800/500mg | >80% | 2,114.2 |
| 04857 |  | Sulforhodamine bis(piperazine-PEG5-COOH) | 65,700/0.4mg | >95% | 7.0 |
| 04743 |  | DMT-PEG5-S-Et-OH | 66,300/25mg | >90% | 300.6 |
| 06863 |  | L-Cysteine tetrasulfide | 68,800/0.1mg | >95% | 0 |
| 06861 |  | Glutathione tetrasulfide | 170,000/10mg | >90% | 17.0 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06508 |  | Tos-PEG4-SCSOEt | 72,300/25mg | >95% | 271.5 |
| 06473 |  | DMSI(3-PEG4-COOH) | 64,000/0.7mg | >95% | 4.1 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06433 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 68,800/0.1mg | >90% | 0 |
| 06422 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06409 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 133,000/0.1mg | >95% | 0 |
| 06405 |  | AADIS7-PEG4-N3 | 68,800/0.1mg | >95% | 2.5 |
| 06387 |  | SCSOEt-PEG4-SCSOEt | 66,300/25mg | >90% | 669.7 |
| 06384 |  | Cyclic(-S-PEG4-S-)9 | 149,100/0.1mg | >95% | 0.1 |
| 06383 |  | Cyclic(-S-PEG4-S-)8 | 149,100/0.1mg | >90% | 0.1 |
| 06382 |  | Cyclic(-S-PEG4-S-)7 | 149,100/0.1mg | >90% | 0.1 |
| 06381 |  | Cyclic(-S-PEG4-S-)6 | 149,100/0.1mg | >90% | 0.1 |
| 06380 |  | Cyclic(-S-PEG4-S-)5 | 149,100/0.1mg | >90% | 0.1 |
| 06379 |  | Cyclic(-S-PEG4-S-)4 | 149,100/0.1mg | >90% | 0.1 |
| 06378 |  | Cyclic(-S-PEG4-S-)3 | 149,100/0.1mg | >90% | 0.1 |
| 06353 |  | Cyclic(-S-PEG4-S-)4 | 83,800/0.1mg | >95% | 0 |
| 06352 |  | Cyclic(-S-PEG4-S-)3 | 83,800/0.1mg | >95% | 0 |
| 06343 |  | Cyclic(-S-PEG4-S-)2 | 149,100/0.1mg | >95% | 0.1 |
| 06340 |  | SH-PEG4-SS-PEG4-SH | 84,100/0.7mg | >90% | 34.0 |
| 06293 |  | TMSI-PEG4-Pr-COOH | 64,000/0.7mg | >95% | 0 |
| 06062 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 06059 |  | AADIS7-PEG4-COOMe | 133,000/0.1mg | >95% | 3.9 |
| 06009 |  | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05970 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 05948 |  | TMSI-PEG4-OH | 68,800/0.2mg | >95% | 15.7 |
| 05344 |  | DMT-PEG4-S-Et-OAc | 64,900/75mg | >80% | 426.3 |
| 05075 |  | AADIS7-PEG3-OAc | 65,700/0.4mg | >95% | 3.0 |
| 04712 |  | SH-PEG4-SH | inquire | >90% | 60.0 |
| 04674 |  | SCNHNH2-PEG4-SCNHNH2 | 68,900/25mg | >95% | 1,350.9 |
| 04673 |  | Tos-PEG4-SCNHNH2 | 63,400/50mg | >95% | 776.1 |
| 04243 |  | DMT-PEG4-SCSOEt | 72,300/25mg | >95% | 158.6 |
| 03828 |  | Trt-PEG3-S-Et-OH | 65,300/10mg | >90% | 408.1 |
| 03545 |  | TMSI-PEG4-COOMe | 68,800/0.1mg | >95% | 1.6 |
| 02292 |  | DMT-PEG4-SS-PEG4-OTos | 72,500/5mg | >95% | 30.8 |
| 02196 |  | Trt-PEG4-SH | 68,100/0.2mg | >95% | 1.8 |
| 02194 |  | DMT-PEG4-SS-Et-OH | 70,000/25mg | >95% | 371.1 |
| 02193 |  | Trt-PEG4-SS-Et-OTos | 72,500/5mg | >95% | 0 |
| 01266 |  | Trt-PEG4-SS-PEG4-N3 | 70,800/2.5mg | >90% | 0 |
| 06860 |  | Glutathione trisulfide | 170,000/30mg | >90% | 99.5 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06450 |  | (OH-PEG3-S-)2 | 80,100/0.7mg | >95% | 7.2 |
| 06431 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06430 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06425 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06423 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06393 |  | TMSI-PEG3-OMe | 64,000/0.7mg | >95% | 11.2 |
| 06358 |  | SH-PEG3-SH | inquire | >90% | 1.3 |
| 06351 |  | Cyclic(-S-PEG3-S-PEG1-)2 | 84,900/0.1mg | >95% | 0 |
| 06346 |  | Cyclic(-S-PEG3-S-CH2-O-CH2-)2 | 84,900/0.1mg | >95% | 0 |
| 06342 |  | Cyclic(-S-PEG3-S-)2 | 84,900/0.1mg | >95% | 0 |
| 06341 |  | SH-PEG3-SS-PEG3-SH | 84,100/0.7mg | >90% | 0 |
| 06061 |  | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 05146 |  | TMSI-PEG3-OH | 68,800/0.1mg | >95% | 89.4 |
| 03842 |  | N3-PEG3-O-Et-SS-Et-PEG3-OH | 75,200/5mg | >95% | 38.9 |
| 03032 |  | DMT-PEG3-NH-Et-SS-Et-NH2 | 70,800/2.5mg | >95% | 37.9 |
| 02597 |  | Trt-PEG3-PPG1-SO3H | 64,900/7.5mg | >95% | 186.0 |
| 02345 |  | TrtNH-PEG3-NHCO-Et-S-COMe | 64,000/5mg | >95% | 98.0 |
| 02065 |  | Trt-PEG3-SSO3H | 64,600/0.5mg | >95% | 26.8 |
| 01905 |  | N3-PEG3-SCSOEt | 67,300/0.5mg | >95% | 77.4 |
| 01636 |  | SO3H-PEG3-OH | 67,300/0.5mg | <80% | 60.0 |
| 01551 |  | Trt-PEG3-SCSOEt | 64,900/7.5mg | >95% | 241.0 |
| 01331 |  | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0 |
| 06864 |  | Glutathione disulfide | 66,100/100mg | >90% | 0 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06510 |  | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 06440 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06439 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 02195 |  | TrtNH-PEG1-S-Et-OH | 70,000/25mg | >90% | 136.0 |
| 04961 |  | 2-(2-trityloxyethyldisulfanyl)ethanol | 64,900/75mg | >95% | 178.4 |
| 01699 |  | SCSOEt-PEG2K-SCSOEt | 66,300/2.5mg | <80% | 353.0 |
| 08734 |  | [(Z)-1-methylsulfonylethylideneamino] N-methylcarbamate | 50,000/1mg | >95% | 0.7 |
| 07517 |  | Dichloroprop methyl ester D3 | 66,300/2.5mg | >95% | 0 |
| 06851 |  | Dichloroprop methyl ester | inquire | >95% | 138.1 |
| 06843 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOAc 8',8'-diMe) | 63,400/0.2mg | >95% | 1.9 |
| 06841 |  | AADIS5(6-Br)(8-N-Pr-SO3H) | 64,000/0.7mg | >95% | 9.1 |
| 06840 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOH 8',8'-diMe) | 65,700/0.4mg | >95% | 0.7 |
| 06790 |  | 3-(5-bromo-2,3,3-trimethyl-pyrrolo[2,3-b]pyridin-7-yl)propane-1-sulfonic acid | 64,000/0.7mg | >95% | 156.7 |
| 06607 |  | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | 66,300/5mg | >95% | 0.2 |
| 06523 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06522 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06520 |  | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >90% | 0 |
| 06519 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 133,000/0.1mg | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06490 |  | 3',6'-bis(3-sulfanylpropoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 68,800/0.1mg | >95% | 0 |
| 06442 |  | [3-oxo-6'-(3-sulfanylpropanoyloxy)spiro[isobenzofuran-1,9'-xanthene]-3'-yl] 3-sulfanylpropanoate | 133,000/0.1mg | >95% | 0 |
| 06418 |  | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06297 |  | AADIS5-Et-OAc | 68,800/0.2mg | >95% | 8.0 |
| 06296 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0.9 |
| 06167 |  | 1-phenyl-5-propylsulfonyl-tetrazole | 68,800/50mg | >95% | 617.8 |
| 06162 |  | 5-butylsulfonyl-1-phenyl-tetrazole | 68,800/50mg | >95% | 1,246.2 |
| 06145 |  | 5-ethylsulfanyl-1-phenyl-tetrazole | 68,800/50mg | >95% | 300.0 |
| 06114 |  | AADIS7-Et-SO3H | 68,800/0.1mg | >80% | 7.6 |
| 06035 |  | TMSI-Et-SO3H | 65,700/0.4mg | >80% | 20.4 |
| 06002 |  | propylene bisdithiocarbamate dimethyl | 64,900/7.5mg | >95% | 890.0 |
| 05969 |  | AADIS5-Hex-COOH | 64,000/0.7mg | >95% | 1.0 |
| 05968 |  | 2-[4-[6'-[4-(carboxymethyl)piperazin-1-yl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3'-yl]piperazin-1-yl]acetic acid | 68,800/0.1mg | >95% | 1.0 |
| 05967 |  | 2-[4-(1,1-dioxo-6'-piperazin-1-yl-spiro[2,1-ramda--benzoxathiole-3,9'-xanthene]-3'-yl)piperazin-1-yl]acetic acid | 68,800/0.1mg | >95% | 0 |
| 05959 |  | AADIS5-Me | 68,800/0.2mg | >95% | 9.3 |
| 05955 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 68,800/0.2mg | >90% | 0.1 |
| 05954 |  | AADIS7-Hex-COOH | 68,800/0.1mg | >95% | 0.1 |
| 05945 |  | TMSI-acetoxyacetic acid | 68,800/0.1mg | >95% | 5.3 |
| 05944 |  | TMSI-Me | inquire | >95% | 3.3 |
| 05941 |  | AADIS5-HexCOOH | 64,000/0.7mg | >95% | 31.2 |
| 05940 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0.5 |
| 05923 |  | (Boc-Cys-OBn)2 | 68,800/0.2mg | >95% | 1.3 |
| 05393 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0.1 |
| 05374 |  | 2-[[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]amino]-2-oxo-acetic acid | 64,000/5mg | >95% | 73.3 |
| 05372 |  | N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]-2-hydroxy-acetamide | 70,000/25mg | >95% | 82.4 |
| 05371 |  | Tos-O-Et-SS-Et-OTos | 66,300/25mg | >95% | 291.6 |
| 05364 |  | AADIS5-Et-SO3H | 105,500/0.1mg | >95% | 2.4 |
| 05342 |  | Sodium 4-dodecylbenzenesulfonate | inquire | >95% | 30.0 |
| 05314 |  | p-n-Dodecylbenzenesulfonic Acid Sodium Salt 13C6 | inquire | >95% | 5.8 |
| 05148 |  | Sulfo-Cy3 bis(IAA) | 68,800/0.2mg | >95% | 0.1 |
| 05147 |  | Sulfo Cy3-diamine | 68,800/0.2mg | >95% | 5.0 |
| 05143 |  | Sulfo-Cy3 | 65,700/0.4mg | >95% | 2.6 |
| 05142 |  | TMSI-Et-OH | 66,300/2.5mg | >95% | 325.6 |
| 05141 |  | TMSI-acetic acid | 63,400/0.2mg | >95% | 13.3 |
| 05132 |  | TMSI-Et-NH2 | 68,800/5mg | >95% | 22.7 |
| 05130 |  | Suflo-Cy3 | 64,000/0.7mg | >95% | 4.7 |
| 05072 |  | AADIS7-Me | 63,400/0.2mg | >95% | 1.7 |
| 05048 |  | Bentazone-D7 | 88,000/20mg | >95% | 0 |
| 05047 |  | Isoprothiolane-D4 | 55,000/20mg | >95% | 0 |
| 05033 |  | Ampicillin-D5 | 77,000/10mg | >95% | 0 |
| 04939 |  | Mono-6-SH-gamma-cyclodextrin | 66,700/5mg | >90% | 170.0 |
| 04938 |  | Mono-6-SH-alpha-cyclodextrin | 64,000/5mg | >90% | 161.0 |
| 04925 |  | Thiuram-D12 | 64,900/7.5mg | >95% | 160.0 |
| 04891 |  | 2-S-Cysteinyldopa | 88,600/0.1mg | >95% | 25.0 |
| 04876 |  | Mono-6-SH-beta-cyclodextrin | 64,000/5mg | >90% | 112.0 |
| 04852 |  | bis-(IAA-piperazinyl) sulforhodamine | 63,400/0.2mg | >95% | 0.9 |
| 04282 |  | Mono TSE succinic acid | 63,400/50mg | >95% | 1,400.0 |
| 04148 |  | 3-[(7-aminophenothiazin-5-ium-3-yl)-(3-sulfopropyl)amino]propane-1-sulfonate(mix isomers) | 68,800/0.1mg | >95% | 3.8 |
| 04136 |  | TMSI-Hex-COOH | inquire | >90% | 740.6 |
| 04132 |  | DMSI(3-Hex-COOH) | 68,800/5mg | >90% | 525.4 |
| 04084 |  | Ethanesulfonic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- | 64,900/7.5mg | >95% | 400.0 |
| 04080 |  | Ethanesulfonic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]- | 70,000/25mg | >95% | 300.0 |
| 03976 |  | n-Octylxanthate potassium salt | 68,800/50mg | >95% | 456.4 |
| 03666 |  | 1-amino-4-(dimethylamino)-2-sulfosulfanyl-benzene | 70,900/500mg | >95% | 5,749.6 |
| 03607 |  | TMSI-K salt | inquire | >90% | 3,225.9 |
| 02909 |  | GSH-S-Bimane | 64,000/0.7mg | >95% | 30.3 |
| 02363 |  | S-tritylmercaptopropionic acid | inquire | >95% | 1,000.0 |
| 02358 |  | rac-(2S)-4-tert-butoxy-2-[[4-tert-butoxy-4-oxo-2-[6-[[rac-(2S)-5-acetylsulfanyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoyl]amino]hexanoylamino]butanoyl]amino]-4-oxo-butanoic acid | 68,800/0.1mg | >95% | 6.0 |
| 02331 |  | Acetylmercaptopropionic acid | inquire | >95% | 856.0 |
| 01980 |  | Cy3-halolinker | 63,400/0.2mg | >95% | 0.1 |
| 01516 |  | Arsenosugar monosulfate | 200,000/<0.1mg | >95% | 0.2 |
| 00656 |  | N-[2-(2-aminoethyldisulfanyl)ethyl]-4-[3-(trifluoromethyl)diazirin-3-yl]benzamide | 70,000/25mg | >95% | 806.0 |
| 00651 |  | 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide-d4 | 68,000/10mg | >95% | 817.0 |
| 00583 |  | C10-SPC | 75,000/10mg | >95% | 15.0 |
| 00582 |  | C8-SPC | 105,500/0.1mg | >95% | 105.0 |
| 00413 |  | 1H-Imidazolium, 1,2-dimethyl-3-[(2,2,2-trichloroethoxy)sulfonyl]-, 1,1,1-trifluoromethanesulfonate | 70,000/25mg | >95% | 466.0 |
| 00352 |  | 2,2,2-Trichloroethyl chlorosulfate | inquire | <80% | 2,521.7 |
